Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11858945 Alkyne-containing antiviral agents

Patent 11858945 was granted and assigned to Enanta Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118589450

Patent Inventor Names

Samuel Bartlett0

Yat Sun Or0

Joseph D. Panarese0

Guoqiang Wang0

Date of Patent

January 2, 2024

Patent Application Number

179834840

Date Filed

November 9, 2022

Patent Citations

‌

US Patent 9290757 Protease screening methods and proteases identified thereby

‌

US Patent 8222288 Small molecule inhibitors of MDM2 and the uses thereof

‌

US Patent 8222425 Organic compounds and their uses

‌

US Patent 8372802 Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

‌

US Patent 11124497 Inhibitors of cysteine proteases and methods of use thereof

‌

US Patent 11174231 Inhibitors of cysteine proteases and methods of use thereof

‌

US Patent 11207370 Peptidomimetics for the treatment of coronavirus and picornavirus infections

‌

US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11858945 Alkyne-containing antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API